Compartment-specific expression of plasminogen activator inhibitor-1 correlates with severity/outcome of murine polymicrobial sepsis

Thrombosis Research

Volumn 129, Issue 5, 2012, Pages

  Raeven, Pierre ^a   Feichtinger, Georg Alexander ^a   Weixelbaumer, Katrin Maria ^a   Atzenhofer, Simone ^a   Redl, Heinz ^a   Van Griensven, Martijn ^a   Bahrami, Soheyl ^a   Osuchowski, Marcin Filip ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

Author keywords

Cecal ligation and puncture; Endothelium; Fibrinolysis; Gene expression; Liver; Peritonitis

Indexed keywords

ANTITHROMBIN; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; BODY TEMPERATURE; CAVA VEIN; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBRINOLYSIS; GENE EXPRESSION; LIGATION; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PERITONITIS; POLYMICROBIAL SEPSIS; PRIORITY JOURNAL; PUNCTURE; RETROSPECTIVE STUDY; SEPSIS;

ANIMALS; FEMALE; FIBRINOLYSIS; GENE EXPRESSION; MICE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SEPSIS; TREATMENT OUTCOME;

EID: 84860481787     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.02.004     Document Type: Article

References (39)

1. M. Levi, H. Ten Cate, T. Van der Poll, and S.J. van Deventer Pathogenesis of disseminated intravascular coagulation in sepsis JAMA 270 8 1993 975 979
2. J. Kienast, M. Juers, C.J. Wiedermann, J.N. Hoffmann, H. Ostermann, and R. Strauss Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation J Thromb Haemost 4 1 2006 90 97
3. J.F. Dhainaut, A.F. Shorr, W.L. Macias, M.J. Kollef, M. Levi, and K. Reinhart Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure Crit Care Med 33 2 2005 341 348
4. N. Semeraro, C.T. Ammollo, F. Semeraro, and M. Colucci Sepsis, thrombosis and organ dysfunction Thromb Res 2011 Nov 5. [Electronic publication ahead of print]
5. C. Dellas, and D.J. Loskutoff Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease Thromb Haemost 93 4 2005 631 640
6. H.R. Lijnen Pleiotropic functions of plasminogen activator inhibitor-1 J Thromb Haemost 3 1 2005 35 45
7. S. Gando, Y. Nakanishi, and I. Tedo Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome Crit Care Med 23 11 1995 1835 1842
8. A.F. Suffredini, P.C. Harpel, and J.E. Parrillo Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects N Engl J Med 320 18 1989 1165 1172
9. G. Pralong, T. Calandra, M.P. Glauser, J. Schellekens, J. Verhoef, and F. Bachmann Plasminogen activator inhibitor 1: a new prognostic marker in septic shock Thromb Haemost 61 3 1989 459 462
10. S. Madoiwa, S. Nunomiya, T. Ono, Y. Shintani, T. Ohmori, and J. Mimuro Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation Int J Hematol 84 5 2006 398 405
11. K. Madach, I. Aladzsity, A. Szilagyi, G. Fust, J. Gal, and I. Penzes 4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study Crit Care 14 2 2010 R79
12. P.W. Hermans, and J.A. Hazelzet Plasminogen activator inhibitor type 1 gene polymorphism and sepsis Clin Infect Dis 41 Suppl 7 2005 S453 S458
13. G.R. Bernard, J.L. Vincent, P.F. Laterre, S.P. LaRosa, J.F. Dhainaut, and A. Lopez-Rodriguez Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 10 2001 699 709
14. M. Savioli, M. Cugno, F. Polli, P. Taccone, G. Bellani, and P. Spanu Tight glycemic control may favor fibrinolysis in patients with sepsis Crit Care Med 37 2 2009 424 431
15. M.S. Sawdey, and D.J. Loskutoff Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta J Clin Invest 88 4 1991 1346 1353
16. F. Samad, K. Yamamoto, and D.J. Loskutoff Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide J Clin Invest 97 1 1996 37 46
17. K. Yamamoto, and D.J. Loskutoff Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator J Clin Invest 97 11 1996 2440 2451
18. C. Fearns, and D.J. Loskutoff Induction of plasminogen activator inhibitor 1 gene expression in murine liver by lipopolysaccharide. Cellular localization and role of endogenous tumor necrosis factor-alpha Am J Pathol 150 2 1997 579 590
19. M. Colucci, J.A. Paramo, and D. Collen Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation J Clin Invest 75 3 1985 818 824
20. P.H. Quax, C.M. van den Hoogen, J.H. Verheijen, T. Padro, R. Zeheb, and T.D. Gelehrter Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo J Biol Chem 265 26 1990 15560 15563
21. J.J. Emeis, and T. Kooistra Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells J Exp Med 163 5 1986 1260 1266
22. H. Schochl, C. Solomon, A. Schulz, W. Voelckel, A. Hanke, and M. Van Griensven Thromboelastometry (TEM) findings in disseminated intravascular coagulation in a pig model of endotoxinemia Mol Med 17 3-4 2011 266 272
23. L.F. Poli-de-Figueiredo, A.G. Garrido, N. Nakagawa, and P. Sannomiya Experimental models of sepsis and their clinical relevance Shock 30 Suppl 1 2008 53 59
24. W.J. Hubbard, M. Choudhry, M.G. Schwacha, J.D. Kerby, L.W. Rue III, and K.I. Bland Cecal ligation and puncture Shock 24 Suppl 1 2005 52 57
25. S.J. Ebong, D.R. Call, G. Bolgos, D.E. Newcomb, J.I. Granger, and M. O'Reilly Immunopathologic responses to non-lethal sepsis Shock 12 2 1999 118 126
26. S. Ebong, D. Call, J. Nemzek, G. Bolgos, D. Newcomb, and D. Remick Immunopathologic alterations in murine models of sepsis of increasing severity Infect Immun 67 12 1999 6603 6610
27. N. Lindenblatt, M.D. Menger, E. Klar, and B. Vollmar Systemic hypothermia increases PAI-1 expression and accelerates microvascular thrombus formation in endotoxemic mice Crit Care 10 5 2006 R148
28. M.F. Osuchowski, K. Welch, H. Yang, J. Siddiqui, and D.G. Remick Chronic sepsis mortality characterized by an individualized inflammatory response J Immunol 179 1 2007 623 630
29. K.M. Weixelbaumer, P. Raeven, H. Redl, M. Van Griensven, S. Bahrami, and M.F. Osuchowski Repetitive low-volume blood sampling method as a feasible monitoring tool in a mouse model of sepsis Shock 34 4 2010 420 426
30. T.D. Schmittgen, and K.J. Livak Analyzing real-time PCR data by the comparative C(T) method Nat Protoc 3 6 2008 1101 1108
31. D. Rittirsch, L.M. Hoesel, and P.A. Ward The disconnect between animal models of sepsis and human sepsis J Leukoc Biol 81 1 2007 137 143
32. J.G. Ganopolsky, and F.J. Castellino A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model Am J Pathol 165 4 2004 1433 1446
33. N.I. Shapiro, K. Yano, M. Sorasaki, C. Fischer, S.C. Shih, and W.C. Aird Skin biopsies demonstrate site-specific endothelial activation in mouse models of sepsis J Vasc Res 46 5 2009 495 502
34. S.Q. van Veen, M. Levi, A.K. van Vliet, S. Florquin, T.M. van Gulik, and M.A. Boermeester Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis Crit Care Med 34 11 2006 2799 2805
35. H. Brogren, K. Wallmark, J. Deinum, L. Karlsson, and S. Jern Platelets retain high levels of active plasminogen activator inhibitor 1 PLoS One 6 11 2011 e26762
36. M. Schouten, W.J. Wiersinga, M. Levi, and T. Van der Poll Inflammation, endothelium, and coagulation in sepsis J Leukoc Biol 83 3 2008 536 545
37. N.I. Shapiro, P. Schuetz, K. Yano, M. Sorasaki, S.M. Parikh, and A.E. Jones The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis Crit Care 14 5 2010 R182
38. J. Raaphorst, A.B. Johan Groeneveld, A.W. Bossink, and H.C. Erik Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients Thromb Haemost 86 2 2001 543 549
39. P.M. Jansen, R.A. Pixley, M. Brouwer, I. de J, A.C. Chang, and C.E. Hack Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase Blood 87 6 1996 2337 2344